Halogenated Cyclooctynes for Bioconjugation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cycloaddition reactions involving cyclooctynes face challenges in optimizing both polarity and reactivity, particularly in achieving high water solubility while maintaining effective reaction rates, and there is a lack of applications for halogenated aryl azides in strain-promoted cycloaddition reactions.

Innovation Solution

A process involving the reaction of a halogenated 1,3-dipole compound with a (hetero)cycloalkyne, specifically a halogenated 1,3-dipole compound comprising substituents like F, Cl, or I, and a (hetero)cycloalkyne according to a defined formula, to enhance reaction efficiency and solubility, and the use of halogenated aryl azides for photoaffinity labeling through strain-promoted cycloaddition.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If hydrocarbon-based cyclooctynes are used, then reaction rate is high, but water solubility is poor

Engineering Contradiction:
Improvereaction rateVSAvoidwater solubility
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent applies local quality by introducing polar halogen substituents (F, Cl, Br, I) at specific positions on the cyclooctyne ring structure. This creates local polar regions that enhance water solubility without compromising the overall reaction rate, as the strained alkyne functionality remains intact for high-reactivity cycloaddition with 1,3-dipoles.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes the chemical parameters of the cyclooctyne by substituting hydrogen atoms with halogen atoms. This modification alters both the polarity and solubility characteristics while maintaining the core cyclooctyne structure and its strained alkyne functionality, thereby achieving improved water solubility without sacrificing reaction rate.

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If polar substituents are added to enhance water solubility, then solubility improves, but reaction rate decreases

Engineering Contradiction:
Improvewater solubilityVSAvoidreaction rate
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent strategically places halogen substituents at specific positions on the cyclooctyne ring that maximize solubility enhancement while minimizing interference with the strained alkyne functionality. This localized modification approach preserves the high reaction rate necessary for effective cycloaddition reactions.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent creates composite molecular structures by combining the hydrophobic cyclooctyne core with polar halogen substituents. This composite structure achieves a balance between water solubility and reactivity, where the halogenated cyclooctyne exhibits both improved solubility characteristics and maintained cycloaddition reactivity.

Inventive Principle:
Principle #40Composite materials

3Reliability

If halogenated 1,3-dipole compounds are used, then photoaffinity labeling efficiency improves, but synthesis complexity increases

Engineering Contradiction:
Improvephotoaffinity labeling efficiencyVSAvoidsynthesis complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs halogenated 1,3-dipole compounds that serve multiple functions: they participate in strain-promoted cycloaddition reactions and simultaneously provide photoaffinity labeling capability through their halogenated aromatic groups. This multi-functionality reduces the need for separate labeling steps and simplifies the overall workflow despite the slightly increased synthesis complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The halogenated aromatic group acts as an intermediary that bridges the cycloaddition reaction and the photoaffinity labeling function. The halogen atoms facilitate both the cycloaddition reactivity and the subsequent photochemical crosslinking, serving as a dual-purpose mediator that enhances labeling efficiency without requiring separate functional groups.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process improves the reaction rate and solubility of cycloaddition products, enabling broader applications in bioconjugation, labeling, and medical uses, and introduces halogenated aryl azides for efficient photoaffinity labeling.

Implementation Method 1

A 1,3-dipolar cycloaddition, also called Huisgen (3+2) cycloaddition, is a chemical reaction between a 1,3-dipole and a dipolarophile to form a five-membered ring

Methodology Applied
Scientific Effect1,3-Dipolar cycloaddition: Chemical Bonding

Implementation Method 2

Strain-promoted azide-alkyne cycloaddition (SPAAC) involves the formation of a 1,2,3-triazole by reaction of an azide with a strained, cyclic alkyne

Methodology Applied
Scientific EffectStrain-promoted cycloaddition: Chemical Bonding

Implementation Method 3

the use of halogenated aryl azides for photoaffinity labeling through strain-promoted cycloaddition

Methodology Applied
Scientific EffectPhotoaffinity labeling: Photopolymerisation

Data Source

PatentUS10266502B2Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyne
Publication Date: 2019.04.23 SYNAFFIX BV
  • US10266502B2 patent drawing
  • US10266502B2 patent drawing
  • US10266502B2 patent drawing

AI summary

The present invention relates to a cycloaddition process comprising the step of reacting a halogenated aliphatic 1,3-dipole compound with a (hetero)cycloalkyne according to Formula (1): Preferably, the (hetero)cycloalkyne according to Formula (1) is a (hetero)cyclooctyne. The invention also relates to the cycloaddition products obtainable by the process according to the invention. The invention further relates to halogenated aliphatic 1,3-dipole compounds, in particular to halogenated aliphatic 1,3-dipole compounds comprising N-acetylgalactosamine-UDP (GalNAc-UDP), and to halogenated 1,3-dipole compounds comprising (peracylated) N-acetylglucosamine (GlcNAc), N-acetylgalactosamine (GalNAc), N-acetylmannosamine (ManNAc) and N-acetyl neuraminic acid (NeuNAc).